Compare Tata India Pharma & Healthcare Fund vs SBI Healthcare Opportunities Fund
Tata India Pharma & Healthcare Fund
EquitySectoral-Pharma
SBI Healthcare Opportunities Fund
EquitySectoral-Pharma
Risk
Very High
Very High
Rating
2.0
5.0
Min SIP Amount
₹100
₹500
Expense Ratio
2.42
1.99
NAV
₹35.75
₹548.45
Fund Started
04 Dec 2015
04 Jun 1999
Fund Size
₹1511.49 Cr
₹5870.00 Cr
Exit Load
Exit load of 0.25% if redeemed within 30 days.
Exit load of 0.50% if redeemed within 15 days
1 Year
-2.97%
7.37%
3 Year
15.12%
20.57%
5 Year
11.85%
16.17%
Equity
99.72%
95.53%
Cash
0.28%
4.41%
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 7.99% |
Abbott India Ltd. | 5.94% |
Healthcare Global Enterprises Ltd. | 5.92% |
Divi's Laboratories Ltd. | 5.68% |
Dr. Reddy's Laboratories Ltd. | 4.65% |
Apollo Hospitals Enterprise Ltd. | 4.36% |
Rainbow Children's Medicare Ltd. | 4.30% |
Cipla Ltd. | 4.22% |
Torrent Pharmaceuticals Ltd. | 3.76% |
Max Healthcare Institute Ltd. | 3.71% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.14% |
Divi's Laboratories Ltd. | 7.91% |
Acutaas Chemicals Ltd. | 5.03% |
Apollo Hospitals Enterprise Ltd. | 4.45% |
Torrent Pharmaceuticals Ltd. | 4.42% |
Cipla Ltd. | 4.40% |
Laurus Labs Ltd. | 4.05% |
Max Healthcare Institute Ltd. | 3.80% |
Aurobindo Pharma Ltd. | 3.42% |
Aster DM Quality Care Ltd. | 3.21% |
Name
-
-
Start Date
-
-
Description
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
04 Dec 2015
04 Jun 1999
